Breaks Categories: News

WednesdaySep 10, 2025 10:57 am

NetworkNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Reports First-Half 2025 Results, Marks Commercial Debut of Mudra Link

Wearable Devices (NASDAQ: WLDS, WLDSW), a technology growth company specializing in artificial intelligence-powered touchless sensing wearables, announced financial results for the six months ended June 30, 2025, highlighted by the commercial launch of its Mudra Link wristband. The company reported strong revenue momentum from both Mudra Link and Mudra Band, alongside a significantly reduced net loss compared to last year. Management said the results underscore growing demand for intuitive, touchless interfaces and position Wearable Devices as a leader in the global wearables market. CEO Asher Dahan noted continued investment in R&D, marketing and operations, as well as strategic opportunities spanning…

Continue Reading

WednesdaySep 10, 2025 10:40 am

NetworkNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Expands Electric Training Program at Nautical Ventures Dealerships

Vision Marine Technologies (NASDAQ: VMAR), a pioneer in electric marine propulsion, announced the advancement of its Electric Representative Training Program across Nautical Ventures’ Florida dealership network. The program has completed its first phase with the training of Electric Representatives at key locations, enabling customers to receive expert guidance on the company’s proprietary E-Motion(TM) 180E, the first certified 180 HP continuous electric outboard. Vision Marine has already delivered two E-Motion 180E-equipped boats, with more integrations scheduled for delivery in the coming weeks and is now launching on-water training sessions and customer demonstrations. CEO Alexandre Mongeon said the program combines education with…

Continue Reading

WednesdaySep 10, 2025 10:33 am

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma Featured on IBN’s BioMedWire Podcast 

Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology company developing targeted cancer therapies with its proprietary RADR(R) AI platform, is featured in the latest episode of IBN’s BioMedWire Podcast. President, CEO and Director Panna Sharma discusses the company’s mission to accelerate cancer drug development using AI, outlines progress across three ongoing clinical trials and shares his outlook on the future of precision neuro-oncology. To view the full press release, visit https://nnw.fm/429mU About Lantern Pharma Lantern Pharma is an AI company transforming the cost, time, and failure rate of oncology drug discovery and development. Lantern's proprietary AI platform RADR(R) uses machine learning…

Continue Reading

WednesdaySep 10, 2025 10:08 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in NetworkNewsWire Editorial on AI and Robotics in Hospitality

Nightfood Holdings (OTCQB: NGTF) announced its inclusion in a NetworkNewsWire editorial titled “Automation and AI Unlock New Value Across Global Service Industries.” The piece highlights how automation and AI-powered systems are reshaping sectors including manufacturing, health care, retail and logistics, with the most visible transformation occurring in hospitality. Nightfood, which has pivoted to a robotics-first strategy, recently completed its first hotel acquisition to serve as a live deployment site for AI and robotics in hotel operations. With a second property acquisition underway, the company is positioning itself at the forefront of the industry’s technological shift, showcasing how robotics can enhance…

Continue Reading

WednesdaySep 10, 2025 10:00 am

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Reports Final Geophysical Survey Results at Storm Copper Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) announced final results from the MMT geophysical survey at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals under a 20/80 joint venture. CEO Thomas Ullrich said the survey revealed large conductive anomalies consistent with high-grade zones at the Cyclone Deposit, suggesting potential copper sulphide mineralization. He added that permitting, economic studies and feasibility work continue to advance Storm toward a potential mining operation, positioning the project to benefit from strong copper demand driven by electrification, renewable energy and infrastructure growth. To view the full press release, visit https://nnw.fm/pWbCN About…

Continue Reading

WednesdaySep 10, 2025 9:40 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Names Rodney Barreto Chairman, David Phipps CEO

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, announced the appointments of Rodney Barreto as permanent Chairman of the Board and David Phipps as permanent Chief Executive Officer. Both executives had been serving in interim roles since the passing of the company’s previous Chairman and CEO in May. To view the full press release, visit: https://nnw.fm/lL7Yp About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company…

Continue Reading

WednesdaySep 10, 2025 9:30 am

NetworkNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Signs Junior Golf Standout Addison Kloch as Affiliated Athlete

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company delivering performance-driven innovations through physics-based engineering, announced that Addison Kloch, one of Southern California’s top junior golfers, has joined the Newton Golf team as an affiliated athlete. A member of the Class of 2026 from Agoura Hills, California, Kloch recently announced her verbal commitment to play Division I golf at California State University, Fullerton. Her achievements include three-time Marmonte League First Team honors, a 2024 All-Ventura County First Team selection, recognition as California Junior Player of the Year in the Championship Girls Division, and an AJGA Top-300 national ranking. Kloch has…

Continue Reading

WednesdaySep 10, 2025 9:10 am

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Expands Training, Product Strategy with Nation’s Largest Farm and Ranch Retailer

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles, announced the completion of a comprehensive sales and product training session with the largest farm and ranch retailer in the United States. Massimo products are currently available in more than 1,200 of the retailer’s locations, with expansion into 100-plus additional stores planned. Discussions also included broadening the product lineup to feature the new T-Boss 900L UTV, expanded ATV models and growing go-kart offerings. CEO David Shan said the partnership is a cornerstone of Massimo’s growth strategy, helping the company reach families nationwide. Massimo continues to invest in product development and…

Continue Reading

TuesdaySep 09, 2025 11:42 am

NetworkNewsBreaks – VolitionRx (NYSE American: VNRX) Signs Deal with Worldwide Leader in Specialized Diagnostics 

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced a Research License and Exclusive Commercial Option Rights Agreement with Werfen’s Immunoassay Technology Center to assess antiphospholipid syndrome (“APS”) using Volition’s Nu.Q H3.1 Neutrophil Extracellular Traps (“NETs”) assay on Werfen platforms. “We are proud to have entered into this agreement with Werfen, as we implement our strategy to out license our proprietary Nu.Q NETs test to large worldwide companies to leverage their knowledge of specific diseases, product development, regulatory experience and their installed base of proprietary analyzers,” said Gael Forterre, Chief Commercial Officer at Volition. Marta Palicio, Werfen’s Immunoassay…

Continue Reading

TuesdaySep 09, 2025 11:32 am

NetworkNewsBreaks – Gyre Therapeutics (NASDAQ: GYRE) Advances Toward China Approval and Expands Clinical Pipeline With Hydronidone

Gyre Therapeutics (NASDAQ: GYRE) has made strong progress through the first three quarters of FY2025, according to a report by Noble Capital Markets Senior Vice President and Equity Research Analyst Robert LeBoyer. The company posted continued sales growth from two recently launched products, submitted an application for Hydronidone approval in China, and initiated a U.S. Phase 2 trial for the drug. Gyre also named Dr. Han Ying, a board member since January 2025, as CEO. Phase 3 data for Hydronidone in chronic hepatitis B-associated fibrosis met its primary endpoint of fibrosis regression, supporting an NMPA filing in 3Q25. With Breakthrough…

Continue Reading